D-Phenylalanine

D-Phenylalanine

SCHEMBL5288072

N[C@H](Cc1ccccc1)C(=O)O.[Cr]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 4/20 0.96
PTGS1 P23219 2/20 0.96
ALPI P09923 1/20 0.96
PKM P14618 1/20 0.96
XIAP P98170 1/20 0.96
SLC1A3 P43003 2/20 0.67
SLC1A2 P43004 2/20 0.67
SLC1A1 P43005 2/20 0.67
SLC15A1 P46059 1/20 0.61
CYP1A2 P05177 1/20 0.59
LTA4H P09960 1/20 0.58
GRIA2 P42262 1/20 0.57
KDM4E B2RXH2 1/20 0.56
USP2 O75604 1/20 0.56
EGFR P00533 1/20 0.56
LCK P06239 1/20 0.56
FYN P06241 1/20 0.56
ADORA3 P0DMS8 1/20 0.56
ALOX15 P16050 1/20 0.56
HTR2A P28223 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Phenylalanine SCHEMBL3117407 1.00 SLC7A5 (0.96) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL3117414 1.00 SLC7A5 (0.96) SLC7A5PTGS1ALPIPKMXIAP
Dl-Phenylalanine SCHEMBL991787 1.00 SLC7A5 (0.96) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL991789 1.00 SLC7A5 (0.96) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL23159186 0.98 SLC7A5 (1.00) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL8119 0.98 SLC7A5 (1.00) SLC7A5PTGS1ALPIPKMXIAP
Dl-Phenylalanine SCHEMBL16398196 0.98 SLC7A5 (1.00) SLC7A5PTGS1ALPIPKMXIAP
Dl-Phenylalanine SCHEMBL8118 0.98 SLC7A5 (1.00) SLC7A5PTGS1ALPIPKMXIAP
Dl-Phenylalanine SCHEMBL385804 0.98 SLC7A5 (1.00) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL16398197 0.98 SLC7A5 (1.00) SLC7A5PTGS1ALPIPKMXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7271278-B2 Application of chromium-amino acid complexes in the treatment of diabetes and other diseases THE UNIVERSITY OF WYOMING (US) 2007-09-18 US disclosed
US-20070015826-A1 Application of chromium-amino acid complexes in the treatment of diabetes and other diseases NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-01-18 US disclosed
WO-2007002739-A2 CHROMIUM-AMINO ACID COMPLEXES IN THE TREATMENT OF DIABETES AND OTHER DISEASES THE UNIVERSITY OF WYOMING (US) 2007-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015826-A1 Application of chromium-amino acid complexes in the treatment of diabetes and other diseases BCAT1, IAPP, BCAT2 SLC7A5 53/4885PTGS1 4579/4885ALPI 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.